{"id":474166,"date":"2021-04-09T08:04:03","date_gmt":"2021-04-09T12:04:03","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=474166"},"modified":"2021-04-09T08:04:03","modified_gmt":"2021-04-09T12:04:03","slug":"schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/","title":{"rendered":"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery"},"content":{"rendered":"

<\/p>\n

Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery<\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nSchr\u00f6dinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid, Ph.D., chief executive officer at Schr\u00f6dinger, will participate in a panel during the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery. The panel will take place virtually on Friday, April 16, at 10:00 a.m. ET.\n<\/p>\n

\nThe \u201con demand\u201d webcast can be accessed under “News & Events” in the investors section of Schr\u00f6dinger\u2019s website<\/a>, https:\/\/ir.schrodinger.com\/news-and-events\/event-calendar<\/a> and will be archived for approximately 7 days.\n<\/p>\n

About Schr\u00f6dinger<\/b><\/p>\n

\nSchr\u00f6dinger is transforming the way therapeutics and materials are discovered. Schr\u00f6dinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schr\u00f6dinger\u2019s multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.\n<\/p>\n

\nFounded in 1990, Schr\u00f6dinger has over 450 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com<\/a> and follow us on LinkedIn<\/a> and Twitter<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210409005031\/en\/<\/a><\/span><\/p>\n

\nJaren Irene Madden
\n
Schr\u00f6dinger, Inc.
\n
jaren.madden@schrodinger.com
\n<\/a>
617-286-6264\n<\/p>\n

\nStephanie Simon (media)
\n
Ten Bridge Communications
\n
617-581-9333\n<\/p>\n

KEYWORDS:<\/b> United States North America New York<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Health Pharmaceutical Technology Software<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery NEW YORK–(BUSINESS WIRE)– Schr\u00f6dinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid, Ph.D., chief executive officer at Schr\u00f6dinger, will participate in a panel during the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery. The panel will take place virtually on Friday, April 16, at 10:00 a.m. ET. The \u201con demand\u201d webcast can be accessed under “News & Events” in the investors section of Schr\u00f6dinger\u2019s website, https:\/\/ir.schrodinger.com\/news-and-events\/event-calendar and will be archived for approximately 7 days. About Schr\u00f6dinger Schr\u00f6dinger is transforming the way therapeutics and materials are discovered. Schr\u00f6dinger has pioneered a physics-based software platform that enables discovery of high-quality, … <\/p>\n

Continue reading “Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-474166","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSchr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery NEW YORK–(BUSINESS WIRE)– Schr\u00f6dinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid, Ph.D., chief executive officer at Schr\u00f6dinger, will participate in a panel during the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery. The panel will take place virtually on Friday, April 16, at 10:00 a.m. ET. The \u201con demand\u201d webcast can be accessed under “News & Events” in the investors section of Schr\u00f6dinger\u2019s website, https:\/\/ir.schrodinger.com\/news-and-events\/event-calendar and will be archived for approximately 7 days. About Schr\u00f6dinger Schr\u00f6dinger is transforming the way therapeutics and materials are discovered. Schr\u00f6dinger has pioneered a physics-based software platform that enables discovery of high-quality, … Continue reading "Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-09T12:04:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery\",\"datePublished\":\"2021-04-09T12:04:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/\",\"name\":\"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-04-09T12:04:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/","og_locale":"en_US","og_type":"article","og_title":"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery - Market Newsdesk","og_description":"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery NEW YORK–(BUSINESS WIRE)– Schr\u00f6dinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid, Ph.D., chief executive officer at Schr\u00f6dinger, will participate in a panel during the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery. The panel will take place virtually on Friday, April 16, at 10:00 a.m. ET. The \u201con demand\u201d webcast can be accessed under “News & Events” in the investors section of Schr\u00f6dinger\u2019s website, https:\/\/ir.schrodinger.com\/news-and-events\/event-calendar and will be archived for approximately 7 days. About Schr\u00f6dinger Schr\u00f6dinger is transforming the way therapeutics and materials are discovered. Schr\u00f6dinger has pioneered a physics-based software platform that enables discovery of high-quality, … Continue reading \"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-09T12:04:03+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery","datePublished":"2021-04-09T12:04:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/","name":"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-04-09T12:04:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210409005031r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/schrodinger-to-participate-in-bmo-biopharma-spotlight-series-technology-enabled-drug-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Schr\u00f6dinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/474166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=474166"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/474166\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=474166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=474166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=474166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}